Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: inattention  road  safety  rac  wa  perth  western  australia  rehabilitation  institute  chicago  ric  health  hospitals  bionics  amputations  technology  multivu  63339  royal  caribbean  sea  travel  cruise  activities  quantum  class  ship  design  genevieve  gorder  hospitality  guests  multivu  55595  sanofi  pasteur  clostridium  difficile  infection  vaccine  bacteria  cdiffense  health  study  multivu  62652  success-story  hospitality-services  college-progams  centennial-college  college-in-toronto  childrens  hospital  philadelphia  chop  buerger  center  advanced  pediatric  care  new  outpatient  medical  facility  multivu  marriott  hotels  travel  brilliantly  travel  lodging  resorts  design  advertising  campaign  hospitality  multivu  5418  hill-rom  hand  hygiene  hospital  acquired  infections  health  hand  washing  disease  technology  multivu  61990  childrens  hospital  philadelphia  chop  fetal  surgery  birth  defects  pediatric  medicine  innovations  multivu  62038  childrens  hospital  philadelphia  chop  fetal  surgery  milestone  spina  bifida  birth  defects  pregnancy  multivu  62038  wounded  warriors  vet  to  vet  usa  vahospital  trauma  centers  dallas  va  bonham  va  sam  rayburn  memorialveterans  center  waco  va  san  antonio  va  temple  va  poem 
Search // hospital
Results 97-108 of 150 for ' hospital ' (0 seconds)
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma. A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia. “We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.” To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Categories // People and Blog 
Added: 4602 days ago by MultiVuVideo
Runtime: 4m41s | Views: 4606 | Comments: 0
Not yet rated
 

 

 

Bobby Hurley, former All-American guard at Duke and current assistant coach of the University of Rhode Island men’s basketball team, and Travis Ford, two-time SEC tournament MVP at Kentucky and current Oklahoma State University head coach, traded in their playbooks for chore lists at the “LG Home Court Challenge” during the NCAA® Final Four® weekend. LG Electronics USA, an official Corporate Partner of the NCAA, hosted the competition and donated a total of $20,000 in the participating coaches’ names to Coaches vs. Cancer® and the MD Anderson Children’s Cancer Hospital. To view Multimedia News Release, go to http://www.multivu.com/mnr/54895-ncaa-coaches-face-off-lg-home-court-challenge-men-s-final-four-weekend
Categories // Sport  News and Politics 
Added: 4646 days ago by MultiVuVideo
Runtime: 2m1s | Views: 6463 | Comments: 1
Not yet rated
 

 

 

Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis. The study involved 104 infants, children and young adults with advanced neuroblastoma, a cancer of the sympathetic nervous system. Investigators discovered the ATRX gene was mutated only in patients age 5 and older. The alterations occurred most often in patients age 12 and older. These older patients were also more likely than their younger counterparts to have a chronic form of neuroblastoma and die years after their disease is diagnosed. To view Multimedia News Release, go to http://www.multivu.com/mnr/52992-st-jude-pediatric-cancer-genome-project-neuroblastoma-research
Categories // Science and Technology 
Added: 4666 days ago by MultiVuVideos
Runtime: 3m25s | Views: 4537 | Comments: 0
Not yet rated
 

 

 

http://www.youtube.com/watch?v=yXMddEIdusg[EXTRACT] Dr. Samuel Aguiar Jr. - Hospital do Câncer - AC CamargoMédico do Departamento de Cirurgia Pélvicahttp://199.238.143.96/index.php?option=com_content&task=view&id=29&Itemid=33
Categories // Miscellaneous 
Added: 4668 days ago by johngeltkn
Runtime: 3m45s | Views: 5807 | Comments: 0
Not yet rated
 

 

 

University Hospitals (UH) Case Medical Center has announced a $250 million initiative that promises to dramatically change how drugs will advance from discovery in the laboratories to commercialization, resulting in greater access to advanced treatments and cures for patients. The first-of-its-kind initiative, named The Harrington Project for Discovery & Development, is powered by a $50 million gift – the largest donation in the health system’s history – from the Harrington family, recognized entrepreneurs and philanthropists in Cleveland. To view Multimedia News Release, go to http://www.multivu.com/mnr/54909-university-hospitals-uh-harrington-discovery-institute-development-project
Categories // News and Politics 
Added: 4680 days ago by MultiVuVideos
Runtime: 2m53s | Views: 5641 | Comments: 0
Not yet rated
 

 

 

Doctors at Children’s Hospital Boston are just another step closer to securing a cure for sickle cell disease thanks to a little help from some superstar friends. More than $1 million was raised in support of their research efforts on Sunday, January 15 during the “Play Without Pain: Children’s Sickle Cell Benefit,” a partnership with international megastar Celine Dion, Caesars Entertainment, AEG Live and Children’s Hospital Boston. Held at Caesars Palace, the evening included a performance of Celine Dion’s glamorous show directed by Grammy Awards producer Ken Ehrlich, including a touching tribute to sickle cell victims during her rendition of Billy Joel’s “Lullabye.” To view Multimedia News Release, go to http://www.multivu.com/mnr/54153-celine-dion-play-without-pain-children-s-sickle-cell-benefit
Categories // Event and Party  People and Blog 
Added: 4717 days ago by MultiVuVideos
Runtime: 6m53s | Views: 6962 | Comments: 0
Not yet rated
 

 

 

New findings from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form. The finding also led investigators to a new treatment target and possible therapy for the rare childhood tumor of the retina, the light-sensing tissue at the back of the eye. The study appears in the January 11 advance online edition of the scientific journal Nature. To view Multimedia News Release, go to http://www.multivu.com/mnr/46767-st-jude-genome-project-treatment-childhood-eye-tumor-retinoblastoma
Categories // News and Politics 
Added: 4721 days ago by MultiVuVideos
Runtime: 5m1s | Views: 4180 | Comments: 0
Not yet rated
 

 

 

Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from a seemingly similar leukemia associated with a much better outcome. The findings from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project (PCGP) highlight a possible new strategy for treating patients with this more aggressive cancer. The work provides the first details of the genetic alterations fueling a subtype of acute lymphoblastic leukemia (ALL) known as early T-cell precursor ALL (ETP-ALL). The results suggest ETP-ALL has more in common with acute myeloid leukemia (AML) than with other subtypes of ALL. The study appears in the January 12 edition of the journal Nature. To view Multimedia News Release, go to http://www.multivu.com/mnr/46768-st-jude-cancer-genome-sequencing-project-combat-aggressive-leukemia
Categories // Science and Technology 
Added: 4721 days ago by MultiVuVideos
Runtime: 3m59s | Views: 4437 | Comments: 0
Not yet rated
 

 

 

Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss. To view Multimedia News Release, go to http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss
Added: 4724 days ago by MultiVuVideo
Runtime: 1m40s | Views: 4486 | Comments: 0
Not yet rated
 

 

 

Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces the FDA clearance of the pocket-sized PICO◊ system, a single use Negative Pressure Wound Therapy (NPWT) system. PICO is cleared for use both in a hospital and homecare setting and expands the use of NPWT from the traditional wound care population to include a wider range of patients undergoing orthopaedic surgery, plastic surgery and general surgical procedures. This FDA clearance follows the recent successful launch of PICO in Europe, Canada, and Australia. To view Multimedia News Release, go to http://www.multivu.com/mnr/51011-smith-nephew-pico-system-fda-approval-npwt
Categories // Science and Technology 
Added: 4731 days ago by MultiVuVideos
Runtime: 0m35s | Views: 5209 | Comments: 0
Not yet rated
 

 

 

Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K. The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego. To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
Categories // Science and Technology 
Added: 4757 days ago by MultiVuVideos
Runtime: 4m58s | Views: 4253 | Comments: 0
Not yet rated
 

 

 

Prem Rabindranauth, MD, a heart surgeon at Gundersen Lutheran Health System in La Crosse, Wis., is using an exciting technique, called minimally invasive coronary surgery (MICS), to perform heart bypass surgery. To perform MICS, a very small three-inch cut is made between the ribs instead of the long cut through the breast bone that is needed with traditional open heart surgery. This means less pain and blood loss, fewer risks for problems, shorter hospital stays and quicker healing time. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gundluth/49124/
Categories // News and Politics 
Added: 4758 days ago by MultiVuVideos
Runtime: 4m29s | Views: 6396 | Comments: 0
Not yet rated
 

 

 

Page 9 of 13  |  Go to page     |  ««FIRST «Previous  Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.